Clinical Trial Update: A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease [Phase 1]

View source ↗

Summary

HB-2121 is being evaluated in a first-in-patient Phase 1 study as a diagnostic for celiac disease, focusing on safety and tolerability; the trial is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• HB-2121

Snippet

Sponsor: Nielsen Fernandez-Becker | Conditions: Celiac Disease | Phase 1 | Status: RECRUITING